Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Moberg Derma has entered into a distribution agreement with Pharmaplan for Nalox/Emtrix, indicated for nail psoriasis, in South Africa.
Subscribe to our email newsletter
As per the agreement Pharmaplan has exclusive rights to market and sell Nalox /Emtrix in South Africa.
Moberg is responsible for production and supply of the product.
Nalox is a prescription free, over-the-counter product sold under the name Emtrix in certain markets and under the name Kerasal Nail in the US.
Nalox has a rapid mechanism of action which brings visible improvements within 2-4 weeks of treatment.
Moberg Derma president and CEO Peter Wolpert said the company is looking forward to make the product available to the patients in South Africa through the cooperation with Pharmaplan.